Adma Biologics ADMA
NASDAQ ADMA
$9.72 -0.21 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Price to FCF (2023 - 2026)

Updated

Adma Biologics' (ADMA) Price to FCF stood at 16.20 in Q2 2026, down 75.5% from 66.05 a year earlier and down 16.5% from the prior quarter.

Analysis

Adma Biologics (ADMA) Price to FCF (2023 - 2026) Analysis & Trends

For FY2025, Adma Biologics' Price to FCF came in at 155.96, up 324.5% from FY2024.

  • Across earlier years, Price to FCF came in at 36.74 in FY2024 (-85.5%) and 253.61 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Price to FCF in data going back to Q4 2023.
  • On a year-over-year basis, Price to FCF rose in three of the last seven quarters, with growth averaging 24.1%.
  • Per Business Quant, the preceding three quarters came in at 19.40 (Q1 2026), 155.96 (Q4 2025) and 85.79 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Adma Biologics 2.24 Bn 1.81 Bn 86.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.20
Mar 31, 2026 19.40
Dec 31, 2025 155.96
Sep 30, 2025 85.79
Jun 30, 2025 66.05
Mar 31, 2025 52.21
Dec 31, 2024 36.74
Sep 30, 2024 59.52
Jun 30, 2024 39.09
Mar 31, 2024 94.82
Dec 31, 2023 253.61
API Access

Adma Biologics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=ADMA&period=max&api_key=YOUR_API_KEY